Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Elevating the Conversation

Jun 1, 2018/Column

A PT's journey to pelvic health advocacy

International Hip Outcome Tool (iHOT-33, iHOT-12)

Nov 3, 2023/Test & Measure

The International Hip Outcome Tool (iHOT) was developed to measure quality of life for active patients with hip disorders.

Adopt the Rule of 7

Mar 1, 2020/Column

Try adding engagement and impact to everything you do.

Failure to Report

Jun 1, 2019/Column

Sometimes you need to walk away. But that's not all.

Response to Stress Questionnaire (RSQ)

Apr 29, 2022/Test & Measure

The Response to Stress Questionnaire measures stressor or domain-specific coping and involuntary responses to stress.

APTA to CMS: It’s Time to Reduce Admin Burden and Simplify the Delivery of Care

Jun 16, 2025/Article

The association has taken the lead on advocating for regulatory reforms and deregulation to improve the delivery of physical therapy.

William Coughlan, Former APTA CEO, Dies at 77

Jan 9, 2024/News

Coughlan helped to lead significant growth at APTA in the late 1980s and early 1990s.

Top APTA Podcasts of 2024

Jan 10, 2025/News

APTA Podcasts helped you inform your practice, gain insight into regulatory issues, and explore professional ethics.

State of Direct Access to Physical Therapist Services: A Report from the American Physical Therapy Association

Jun 25, 2025/Report (Open Access)

APTA’s "State of Direct Access to Physical Therapist Services" report is a strategic resource designed to equip health care leaders with the scientific evidence they need to address opposition to direct access and drive meaningful change. 

Are Interventions Delivered and Received as Intended? Author Interview With Kathleen Mangione, PT, PhD

Aug 27, 2021/Podcast

PTJ Editor-in-Chief Alan Jette, PT, PhD, FAPTA, talks with Kathleen Mangione, PT, PhD, FAPTA, about something critically important to physical therapists but rarely top of mind: treatment fidelity.